Skip to main content
Book cover

Prostate Cancer Prevention

  • Book
  • © 2014

Overview

  • Wide-ranging coverage of recent evidence on the prevention of prostate cancer, of interest for both clinicians and researchers
  • Detailed discussion of risk prediction biomarkers
  • Evaluation of the potential role of various means of chemoprevention
  • Includes supplementary material: sn.pub/extras

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 202)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (18 chapters)

Keywords

About this book

Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimination between aggressive and indolent forms are important clinical goals and the acquisition of significant new evidence on means of achieving these aims makes this book particularly timely. A wide range of topics are covered by leading authorities in the field. The biology and natural history of prostate cancer are reviewed and the role of lifestyle and dietary factors, assessed. Detailed attention is paid to risk prediction biomarkers and to the role of novel high-throughput nucleic acid-based technologies in improving risk prediction and thereby allowing tailored approaches to cancer prevention. Potential means of chemoprevention of prostate cancer are also reviewed in depth, covering the very positive new data on the impact of aspirin as well as evidence regarding 5α-reductase inhibitors, DFMO and lycopene. Guidance is provided on the differentiation of aggressive from indolent disease and the policy and research implications of recent findings are examined. This book will be of interest to both clinicians and researchers.

Reviews

From the reviews:

“Part of the Recent Advances in Cancer Research series, this book’s title suggests that it tackles prevention of prostate cancer. … scientists and clinicians who deal with prostate cancer are the main audience. … The discussion of agent development and strategies is very useful to anyone looking to tackle the challenging area of prostate cancer chemoprevention.” (Leonard G. Gomella, Doody’s Book Reviews, May, 2014)

Editors and Affiliations

  • Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine Queen Mary University of London, London, United Kingdom

    Jack Cuzick, Mangesh A. Thorat

Bibliographic Information

  • Book Title: Prostate Cancer Prevention

  • Editors: Jack Cuzick, Mangesh A. Thorat

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-45195-9

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2014

  • Hardcover ISBN: 978-3-642-45194-2Published: 03 March 2014

  • Softcover ISBN: 978-3-662-52443-5Published: 03 September 2016

  • eBook ISBN: 978-3-642-45195-9Published: 15 February 2014

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: VIII, 169

  • Number of Illustrations: 7 b/w illustrations, 4 illustrations in colour

  • Topics: Oncology, Urology, Cancer Research

Publish with us